2seventy bio Inc (TSVT)
4.28
-0.23
(-5.10%)
USD |
NASDAQ |
May 28, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Gross Profit (Quarterly): 7.936M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.936M |
December 31, 2023 | 7.537M |
September 30, 2023 | 7.075M |
June 30, 2023 | 31.53M |
March 31, 2023 | 37.33M |
December 31, 2022 | 51.68M |
September 30, 2022 | 9.447M |
June 30, 2022 | 4.946M |
Date | Value |
---|---|
March 31, 2022 | -0.80M |
December 31, 2021 | 6.308M |
September 30, 2021 | 18.94M |
June 30, 2021 | -2.83M |
March 31, 2021 | 10.20M |
December 31, 2020 | 8.406M |
September 30, 2020 | 17.12M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-2.83M
Minimum
Jun 2021
51.68M
Maximum
Dec 2022
14.32M
Average
8.406M
Median
Dec 2020
Gross Profit (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 8.933B |
Johnson & Johnson | 14.87B |
Macrogenics Inc | 6.988M |
Akebia Therapeutics Inc | 21.00M |
Tango Therapeutics Inc | -- |